"Synergy Research Centers is a Research Institute and clinical research trial center in National City, CA dedicated to curing and treating mental illness and physical disease. Our medical research facility (with two locations in San Diego County) has been conducting clinical research studies for over 18 years. Our team is dedicated to finding solutions to diseases and disorders that afflict millions of people around the world, including depression, diabetes, schizophrenia, bipolar disorder and Alzheimer’s disorder. By participating in our medical research studies, you are helping to find a cure or realistic treatment for those suffering from debilitating mental and physical ailments."

During the past decade, Synergy Clinical Research Center conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 75 clinical trials were completed, i.e. on average, 105.6% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 42 clinical trials were completed. i.e. 161.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synergy Clinical Research Center" #1 sponsor was "Pfizer" with 18 trials, followed by "Sunovion" with 12 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 7 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 6 trials sponsored and "Allergan" with 6 trials sponsored. Other sponsors include 93 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Synergy Clinical Research Center" #1 collaborator was "BrainCells Inc." with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator, "Purdue Pharma LP" with 2 trials as a collaborator and "Takeda" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Synergy Clinical Research Center" are "Schizophrenia" (38 trials), "Major Depressive Disorder" (15 trials), "Depressive Disorder, Major" (10 trials), "Alzheimer's Disease" (7 trials) and "ADHD" (4 trials). Many other conditions were trialed in "Synergy Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Synergy Clinical Research Center" are "Drug" (140 trials), "Other" (9 trials), "Biological" (3 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (73 trials), "placebo" (8 trials), "Rapastinel" (7 trials), "Lurasidone" (5 trials) and "Xanomeline and Trospium Chloride Capsules" (4 trials). Other intervention names were less common.

The vast majority of trials in "Synergy Clinical Research Center" are 143 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Synergy Clinical Research Center". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 105 completed trials in Synergy Clinical Research Center, undefined suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Synergy Clinical Research Center, 5 "Phase 1" clinical trials were conducted, 57 "Phase 2" clinical trials and 78 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 1 trials that are defined as “Not Applicable".